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This study investigated the relationship between waist circumference and the 
subsequent incidence of type 2 diabetes and the association with insulin resistance and 
beta-cell function in relatively lean Japanese. 
Methods 
The study participants were 3,992 employees (2,533 men and 1,459 women, 35-55 
years old) of a metal-products factory in Japan.  The incidence of diabetes was 
surveyed in annual medical examinations during an 8-year follow-up.  We calculated 
age- and sex-adjusted hazard ratios (HRs) according to the sex-specific quintile of waist 
circumference at baseline.  Differences in baseline insulin resistance (HOMA-IR) and 
beta-cell function (HOMA-B) were compared between participants who developed 
diabetes and those who did not. 
Results  
During the follow-up, 218 participants developed diabetes.  Age- and sex-adjusted 
HRs across the quintiles of waist circumference were 1.78, 1.00 (reference), 1.59, 3.11, 
and 3.30, respectively (p for trend, <0.0001).  The HR for the lowest quintile was 
significantly higher than that for the second quintile.  Among participants with waist 
circumference of the lowest quintile, HOMA-B was lower in those who developed 
diabetes than in those who did not (geometric mean, interquartile range; 33.1, 24.1-45.0 
vs. 54.3, 37.9-74.6; p < 0.001), but HOMA-IR did not differ between these groups. 
Conclusions 
There was a J-shaped relationship between waist circumference and subsequent risk for 
type 2 diabetes in relatively lean Japanese; lower beta-cell function may also increase 
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the risk of diabetes in very lean Japanese. 
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Obesity increases the risk for type 2 diabetes (1-7), with previous reports indicating a 
linear association between the degree of obesity and the incidence of type 2 diabetes in 
Western populations (1-5).  Although the prevalence of obesity is much lower in Asian 
countries than in Western countries, the prevalence of type 2 diabetes has been reported 
to be similar (8) suggesting that the association between obesity and diabetes may be 
different in Asian countries compared with Western countries. 
 
One possible reason for the high frequency of type 2 diabetes in Asians is the presence 
of prominent abdominal fat in Asians compared with Caucasians with a similar body 
mass index (BMI) (9, 10); however, few studies have evaluated the association between 
waist circumference and diabetic risk in Asians (11).  Waist circumference might be a 
useful predictor for diabetes in Asians with high abdominal fat.  
 
In addition to obesity, impairment of early-phase insulin secretion and low pancreatic 
beta-cell mass may play important roles in the development of type 2 diabetes in lean 
Asians (12-15).  Decreased beta-cell function can cause hyperglycemia prior to the 
onset of obesity.  It is possible that not only obese people with insulin resistance but 
also lean people with lower beta-cell function are at high risk for developing type 2 
diabetes.  Recently, a J-curve association between BMI and the incidence of diabetes 
was reported in older Japanese adults (16).  This report suggested that older Japanese 
people with low BMI would also be at higher risk for developing diabetes.  However, 
there have been few prospective studies investigating the relationship of waist 
circumference to future development of diabetes in lean Asian people with observation 
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of beta-cell function and insulin resistance. 
 
In this large-scale, 8-year prospective study of relatively lean Japanese men and women, 
we investigated the relationship between anthropometric indices (BMI and waist 
circumference) and the subsequent risk for developing type 2 diabetes.  The objectives 
of this study were: 1) to investigate whether waist circumference is associated with the 
future risk of diabetes, 2) to determine whether the relationship is linear or J-shaped, 




Research Design and Methods 
The participants were employees of a factory that produces zippers and aluminum 
sashes in Toyama Prefecture, Japan.  Detailed information on the study population has 
been described (17-19).  The Industrial Safety and Health Law in Japan requires 
employers to conduct annual health examinations of all employees.  A survey of the 
incidence of diabetes mellitus was performed during the annual medical examinations 
between 1996 and 2004.  At the baseline examination in 1996, 4,274 (90%) of 4,757 
employees aged 35-55 years received health examinations.  Of these 4,274 potential 
participants, 282 (6.6%) were excluded: 199 were diabetic or had high fasting plasma 
glucose (≥7.0 mmol/L) at the time of the baseline examination, 16 had missing data in 
baseline anthropometric indices, and 67 did not participate in consecutive follow-up 
annual health examinations.  The final study population consisted of 3,992 employees 
(2,533 men and 1,459 women). 
 
The baseline health examination included a medical history, physical examination, 
anthropometric measurements (waist circumference and BMI), and the determination of 
fasting plasma glucose, fasting insulin, glycolated hemoglobin (HbA1c) and serum lipid 
levels.  Height was measured, without shoes, to the nearest 0.1 cm using a stadiometer.  
Weight was measured, with participants wearing only light clothing and no shoes, to the 
nearest 0.1 kg using a standard scale.  BMI was calculated as weight/height2 (kg/m2).  
Waist circumference was determined to the nearest 0.5 cm by measuring from a point 
above the iliac crests and below the lowest rib margin, during minimal respiration in a 
standing position.  Blood pressure was measured once with a mercury 
sphygmomanometer after the subjects had rested for five minutes in a seated position.  
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Trained staff took all of the measurements. 
 
Plasma glucose levels were measured enzymatically (Abbott glucose UV test; Abbott 
Laboratories, Chicago, IL, USA), and plasma insulin levels were determined by 
radioimmunoassay (Shionogi Co., Tokyo, Japan).  HbAlc was measured by 
high-velocity liquid chromatography using a fully automated hemoglobin Alc analyzer 
(Kyoto Daiichi Kagaku, Kyoto, Japan).  Total cholesterol and triglycerides were 
measured by enzyme assay.  HDL-cholesterol was measured by direct method.  
Insulin resistance was calculated by the homeostasis model assessment (HOMA) 
method, using the formula: HOMA-IR = fasting insulin (μU/mL) × fasting plasma 
glucose (mmol/L)/22.5 (20).  The HOMA of beta-cell function (HOMA-B) was 
calculated using the following formula: HOMA-B = 20 × fasting insulin 
(μU/mL)/[fasting plasma glucose (mmol/L) - 3.5] (20). 
 
Participants with HbA1c >6.0% received a 75-g oral glucose tolerance test (OGTT).  
According to the definition of American Diabetes Association (21) and Japanese 
Diabetes Society (22), the diagnosis of diabetes is confirmed by at least one of the 
following observations: 1) fasting plasma glucose concentration ≥7.0 mmol/L (126 
mg/dL), 2) 2-h glucose level ≥11.1 mmol/L (200 mg/dL) in a 75-g OGTT, or 3) 
treatment with insulin or an oral hypoglycemic agent. 
 
A questionnaire was used to identify voluntary health-related behaviors such as alcohol 
consumption, smoking, and habitual exercise.  Participants were classified as either 
nondrinkers or active drinkers.  Active drinkers were further divided into occasional 
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(less than 5 days/week), light (greater than 5 days/week and average amounts less than 
40 g ethanol/day for men and 20 g/day for women), or moderate/heavy (greater than 5 
days/week and average amounts of more than 40 g ethanol/day for men and 20 g/day for 
women) drinkers.  Data were also collected concerning smoking habits (never, 
ex-smoker, or current smoker) and frequency of exercise (no, weak, moderate, or 
strong).  Exercise was defined as the participation in any physical activity such as 
jogging, bicycling, swimming, or tennis that was performed long enough to sweat.  A 
self-administered questionnaire was also used to collect information about a medical 
history of hypertension, dyslipidemia, diabetes, and the use of antidiabetic medication.  
High blood pressure and dyslipidemia were defined by the Japanese criteria of 
metabolic syndrome (23): high blood pressure was defined as a systolic blood pressure 
≥130 mmHg or a diastolic blood pressure ≥85 mmHg; dyslipidemia was defined as 
serum triglycerides ≥1.7mmol/L or HDL-cholesterol ≤1.0 mmol/L.  
 
We calculated the incidence rates and hazard ratios (HRs) of diabetes according to the 
sex-specific quintile of waist circumference and BMI.  The Cox proportional hazard 
model was used to calculate age- and sex-adjusted HRs and multivariate-adjusted HRs.  
In the multivariate-adjusted model, HRs were adjusted simultaneously for potential 
confounders including age, sex, family history of diabetes, smoking habits, alcohol use, 
and exercise frequency.  In each category of quintile of waist circumference or BMI, 
the geometric means and 95% CI of HOMA-IR and HOMA-B were calculated and were 
compared between those who developed type 2 diabetes and those who did not using a 
t-test.  Statistical analysis was conducted with the Statistical Package for the Social 




The baseline characteristics of the study participants are presented in Table 1.  At the 
baseline examinations, the participants had a mean age of 44.4 years for both men and 
women, a mean BMI of 23.2 kg/m2 for men and 22.6 kg/m2 for women, and a mean 
waist circumference of 80.4 cm for men and 72.4 cm for women.  During the 8-year 
follow-up (27,861 person-years), we documented 218 incident cases of diabetes (175 
men and 43 women).  Among these, 172 were diagnosed with diabetes based on high 
fasting plasma glucose levels, 40 were diagnosed according to a 75-g OGTT, and six 
had been treated with hypoglycemic medications.   
 
Table 2 shows the baseline characteristics and incidence of diabetes according to the 
sex-specific quintiles of waist circumference.  Participants with higher waist 
circumference tended to be older, and to have higher values of fasting plasma glucose, 
HbA1c, HOMA-IR, and HOMA-B, and higher prevalence of high blood pressure and 
dyslipidemia (p for trend < 0.001 for all).  There was no significant difference in 
prevalence of family history of diabetes among the quintiles of waist circumference. 
 
The crude incident rates (per 1,000 person-years) across the sex-specific quintiles of 
waist circumference at baseline were 6.3, 4.0, 6.0, 11.1, and 12.8, respectively (Table 2).  
The association between waist circumference and the incidence of diabetes was 
J-shaped.  The age- and sex-adjusted HRs (Model 1) across the quintiles of waist 
circumference were 1.78, 1.00 (reference), 1.59, 3.11, and 3.30, respectively, and the 
HRs of the lowest, the fourth, and the highest quintile of waist circumference were 
significantly higher than that of the second quintile.  Further adjustment for family 
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history of diabetes, alcohol intake, smoking, and physical activity (Model 2), and the 
presence of high blood pressure and dyslipidemia at baseline (Model 3) did not change 
the HRs.  The association became slightly weaker after an additional adjustment for 
fasting plasma glucose at the baseline examination (Model 4).  The results were 
similar for the association between baseline BMI and the incidence of diabetes (Table 3).  
The age- and sex-adjusted HRs across the quintiles of BMI were 1.40, 1.00 (reference), 
1.21, 1.97, and 3.06, but the association was somewhat weaker than that for waist 
circumference.  The HR for the lowest quintile was not significantly higher than that 
for the second quintile.  Additional adjustments for potential confounders did not 
substantially change the HRs (Model 2-4).  The results were similar when we analyzed 
excluding 21 participants who developed diabetes within one year of follow-up. 
 
We evaluated the differences in the baseline insulin resistance and beta-cell function 
between the participants who developed diabetes and those who did not, and examined 
their association with obesity (Table 4).  Among participants in the lowest and the 
second waist circumference quintile, HOMA-B was significantly lower in those who 
developed diabetes than in those who did not; however, there were no differences in 
HOMA-IR between these two groups.  In contrast, among participants in the fourth 
and the highest quintile of waist circumference, HOMA-IR was significantly higher in 
those who developed diabetes than in those who did not, and no significant difference 
was observed in HOMA-B between these groups.  These relationships were somewhat 





In this prospective cohort study of Japanese men and women, there was a J-shaped 
association between abdominal obesity and the incidence of type 2 diabetes.  The risk 
of the lowest quintile of waist circumference was approximately 80% higher than that 
for the second quintile, indicating that very lean Japanese are also at high risk for 
developing diabetes.  Among the lean participants, HOMA-B was lower in those who 
developed diabetes than in those who did not, but there was no difference in HOMA-IR 
between these two groups.  These results suggest that lower beta-cell function 
increases the future risk for developing type 2 diabetes in lean Japanese with a very low 
waist circumference, whereas insulin resistance increases the risk in abdominally obese 
Japanese. 
 
Previous studies have shown that waist circumference is associated with increased risk 
for diabetes, independently of BMI, and that waist circumference is a better predictor 
for diabetes than BMI (1, 2, 6).  Waist circumference is regarded as a more useful 
marker for insulin resistance and metabolic abnormalities, because it is more closely 
associated with visceral adiposity, compared with BMI (24).  Our results show that, in 
obese people, waist circumference was more strongly associated with the future risk for 
type 2 diabetes, compared with BMI, and that waist circumference could effectively 
predict the higher diabetic risk of obese people. 
 
In contrast, previous studies using populations from Western countries have shown that 
the association between waist circumference and the incidence of type 2 diabetes was 
linear, not J-shaped (1-5).  This discrepancy might have resulted from a difference in 
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the degree of obesity between Western and Asian populations.  In our study, the upper 
limit of waist circumference in the lowest quintile was 73 cm for men and 65 cm for 
women, which was lower than that in previous studies (1-5).  These previous studies 
might have been unable to detect a higher risk for developing diabetes in people with 
very low waist circumference. 
 
Racial differences in the association between obesity and the risk for type 2 diabetes 
might also have influenced the results.  Although the prevalence of obesity is much 
lower in Asia than in Western countries, the prevalence of type 2 diabetes is similar 
between the two regions (8), and type 2 diabetes occurs in Asians who are less obese 
(25, 26).  In this study, range of waist circumference in the fourth quintile was 
82.5-86.0cm for men and 74.0-80.0cm for women; these values were somewhat lower 
than the cutoff points of waist circumference proposed by the Japan Medical 
Association (85cm for men and 90cm for women) (23) and also by IDF (90cm for men 
and 80cm for women) (27).  However, multivariate-adjusted hazard ratios for diabetes 
in the fourth quintile were significantly higher than those in the second quintile.  The 
participants with high-normal waist circumference would be also at high risk for 
diabetes even though they were not diagnosed as having abdominal obesity.  The 
definition of abdominal obesity in Asian should be carefully considered from the 
aspects not only to identify the people with CVD risk factors as proposed by several 
previous reports (28-32), but also to detect people at higher risk of future diabetes.  It 
has also been reported that the incidence of type 2 diabetes was significantly higher in 
Asian women than in non-Hispanic White women after adjustment for BMI (33).  
Some factors beyond obesity, including genetics, may also cause the higher risk for type 
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2 diabetes seen in Asian populations.   
 
More Asians have prominent abdominal obesity, compared with those in Western 
countries with a similar BMI (9, 10), indicating that Asians may have a higher 
predisposition to insulin resistance and thus may be at higher risk for developing 
diabetes at a lower BMI, compared with people of European descent.  Furthermore, not 
only insulin resistance but also impaired beta-cell function have been reported to play 
important roles in the development of type 2 diabetes in Asians (14, 34).  We have 
shown that lower beta-cell function may increase the risk for developing diabetes in 
lean Japanese.  Lower beta-cell function may cause hyperglycemia or marked insulin 
resistance in the absence of abdominal obesity in these very lean participants. 
 
A study conducted in a relatively lean Taiwanese population found that waist 
circumference for men and BMI for women were strongly associated with the incidence 
of diabetes (11); however, the shape of the relationship could not be determined because 
the data were analyzed using linear logistic regression analysis.  Recently, a J-curve 
association between BMI and the incidence of diabetes was reported in Japanese men 
and women, aged 60-79 years (16).  It was concluded that aging was a high risk factor 
for developing diabetes, because it is associated with a decline in beta-cell function (35, 
36); however, our results suggest that younger and leaner individuals with decreased 
beta-cell function may also be at increased risk for developing diabetes mellitus. 
 
The strength of our study lies in its relatively large sample size compared with those of 
other Asian studies.  Many previous cohort studies used information collected from 
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self-administered questionnaires, whereas our conclusions are based on more reliable 
data obtained from medical examinations and from determinations of fasting blood 
glucose and insulin levels, HOMA-IR, and HOMA-B.  However, our study sample 
included only people who were employed.  As poor health may exclude some 
individuals from working, the prevalence of obesity and the incidence of diabetes may 
be lower in our sample population than in the general Japanese population.  Another 
limitation of this study was that the classification of diabetes was not exactly evaluated 
in all participants with diabetes.  Some lean people with diabetes may not be type 2 
diabetes, but type 1 diabetes or secondary diabetes.  However, the participants with 
incident diabetes in this study were diagnosed in annual medical check-up with 
relatively mild diabetes (mean HbA1c at diagnosis was 5.9% and was not different 
among the quintile of waist circumference).  Furthermore, the results were similar 
when we evaluated the risk of diabetes in participants excluding those who developed 
diabetes within one year of follow-up, who could have other diseases which may 
influence anthropometric variables and glucose tolerance.  Therefore, most of 
participants who developed diabetes in this study would be type 2 diabetes. 
 
In conclusion, although the absolute incident risk of diabetes is higher in obese people, 
leaner Japanese with a smaller waist circumference would also be at high risk for 
developing type 2 diabetes.  Moreover, lower beta-cell function, but not insulin 
resistance, may increase the future risk of type 2 diabetes.  Greater attention should be 
given to very lean Asians, in addition to obese Asians, for the primary prevention of 








1. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body 
fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The 
Nurses' Health Study. Am J Epidemiol 1997;145:614-619. 
2. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor 
of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, 
waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year 
prospective study. Obes Res 1997;5:16-23. 
3. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, et al. 
Associations of general and abdominal obesity with multiple health outcomes in older 
women: the Iowa Women's Health Study. Arch Intern Med 2000;160:2117-2128. 
4. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal 
adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J 
Clin Nutr 2005;81:555-563. 
5. Meisinger C, Doring A, Thorand B, Heier M, Lowel H. Body fat distribution and risk 
of type 2 diabetes in the general population: are there differences between men and 
women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 2006; 
84:483-489. 
6. The Diabetes Prevention Program Research Group. Relationship of body size and 
shape to the development of diabetes in the diabetes prevention program. Obesity 
2006;14:2107-2117. 
7. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, et al. 




8. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and 
type 2 diabetes in Asia. Lancet 2006;368:1681-1688. 
9. Park YW, Allison DB, Heymsfield SB, Gallagher D. Larger amounts of visceral 
adipose tissue in Asian Americans. Obes Res 2001;9:381-387. 
10. He Q, Horlick M, Thornton J, Wang J, Pierson Jr RN, Heshka S, et al. Sex and race 
differences in fat distribution among Asian, African-American, and Caucasian 
prepubertal children. J Clin Endocrinol Metab 2002;87:2164-2170. 
11. Wang SL, Pan WH, Hwu CM, Ho LT, Lo CH, Lin SL, et al. Incidence of NIDDM 
and the effects of gender, obesity and hyperinsulinaemia in Taiwan. Diabetologia 
1997;40:1431-1438. 
12. Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, et al. 
Earlier appearance of impaired insulin secretion than of visceral adiposity in the 
pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American 
men. Diabetes Care 1995;18:747-753. 
13. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, et al. Glucose 
tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese 
subjects. Diabetes Care 1997;20:1562-1568. 
14. Yoshinaga H, Kosaka. Heterogeneous relationship of early insulin response and 
fasting insulin level with development of non-insulin-dependent diabetes mellitus in 
non-diabetic Japanese subjects with or without obesity. Diabetes Res Clin Pract 
1999;44:129-136. 
15. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development 




16. Sairenchi T, Iso H, Irie F, Fukasawa N, Ota H, Muto T. Underweight as a predictor 
of diabetes mellitus in older adults: A large cohort study. Diabetes Care 
2008;31:583-584. 
17. Morikawa Y, Nakagawa H, Ishizaki M, Tabata M, Nishijo M, Miura K, et al. 
Ten-year follow-up study on the relation between the development of 
non-insulin-dependent diabetes mellitus and occupation. Am J Ind Med 1997;31:80-84. 
18. Ishizaki M, Yamada Y, Morikawa Y, Noborisaka Y, Ishida M, Miura K, et al. The 
relationship between waist-to-hip ratio and occupational status and life-style factors 
among middle-aged male and female Japanese workers. Occup Med (Lond) 
1999;49:177-182. 
19. Sakurai M, Miura K, Takamura T, Ota T, Ishizaki M, Morikawa Y, et al. Gender 
differences in the association between anthropometric indices of obesity and blood 
pressure in Japanese. Hypertens Res 2006;29:75-80. 
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 
Homeostasis model assessment: insulin resistance and beta-cell function from fasting 
plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. 
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus. Diabetes Care 1997;20:1183-1197. 
22. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al.; 
Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. 
Report of the Committee on the classification and diagnostic criteria of diabetes 
mellitus. Diabetes Res Clin Pract 2002;55:65-85.  
23.The Examination Committee of Criteria for Metabolic Syndrome. Definition and 
Criteria of Metabolic Syndrome. J Jpn Soc Int Med 2005;94:794-809 (in Japanese). 
18 
 
24. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, 
et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single 
abdominal cross-sectional image. J Appl Physiol 2004;97:2333-2338. 
25. Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, 
dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong 
Chinese. Int J Obes Relat Metab Disord 1999;23:1136-1142. 
26. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N. Obesity and type 2 diabetes in 
Japanese patients. Lancet 2003;361:85. 
27. Arberti KG, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus 
Group. The metabolic syndrome—a new worldwide definition. Lancet 
2005;366:1059–62. 
28. Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, et al. A 
proposal for the cutoff point of waist circumference for the diagnosis of metabolic 
syndrome in the Japanese population. Diabetes Care 2006;29:1123–4. 
29. Ohkubo T, Kikuya M, Asayama K. A proposal for the cutoff point of waist 
circumference for the diagnosis of metabolic syndrome in the Japanese population. 
Diabetes Care 2006;29:1986–7. 
30. Matoba Y, Inoguchi T, Nasu S, Suzuki S, Yanase T, Nawata H, et al. Optimal cut 
points of waist circumference for the clinical diagnosis of metabolic syndrome in the 
Japanese population. Diabetes Care 2008;31:590-2. 
31. Oka R, Kobayashi J, Yagi K, Tanii H, Miyamoto S, Asano A, et al. Reassessment of 
the cutoff values of waist circumference and visceral fat area for identifying Japanese 
subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008; 79: 474-81. 





waist circumference cutoff values for persons with multiple cardiovascular risk factors 
in Japan: a large cross-sectional study. J Epidemiol 2008;18:37-42. 
33. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, et al. Ethnicity, 
obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 
2006;29:1585-1590. 
34. Kadowaki T, Yoshinaga H. Risk factors for the development of 
non-insulin-dependent diabetes mellitus (NIDDM) in Japan. Diabetes Res Clin Pract 
1994;24 Suppl:S123-127. 
35. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Jarvinen H, Ferrannini E. 
Independent influence of age on basal insulin secretion in nondiabetic humans. 
European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab 
1999;84:863-868. 
36. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, et al. Mechanism of 
the age-associated deterioration in glucose tolerance: contribution of alterations in 
insulin secretion, action, and clearance. Diabetes 2003;52:1738-1748. 
21 
 
Table 1. Baseline characteristics of study participants          
Characteristic Total  Men   Women 
Participants (n) 3,992  2,533  1,459 
Age (y) 44.4 ± 5.8  44.4 ± 5.9  44.4 ± 5.7 
Waist circumference (cm) 77.2 ± 8.8  80.0 ± 7.6  72.4 ± 8.8 
Body mass index (kg/m2) 23.0 ± 2.9  23.2 ± 2.7  22.6 ± 3.2 
Fasting plasma glucose (mmol/l) 4.99 ± 0.49  5.04 ± 0.50  4.90 ± 0.45 
Fasting insulin (μU/ml) 5.6 ± 4.3  5.7 ± 4.8  5.4 ± 3.3 
HbA1c (%) 5.0 ± 0.4  5.0 ± 0.4  4.9 ± 0.4 
HOMA-IR* 1.04 (0.69-1.50)  1.04 (0.67-1.55)  1.03 (0.76-1.43)
HOMA-B* 67.2 (47.0-95.3)  64.5 (43.2-93.3)  72.0 (51.4-98.2)
Systolic blood pressure (mmHg) 119.4 ± 14.1  121.8 ± 14.0  115.3 ± 13.4 
Diastolic blood pressure (mmHg) 74.8 ± 10.6  76.8 ± 10.5  71.5 ± 9.9 
Total cholesterol (mmol/L) 5.31 ± 0.87  5.30 ± 0.86  5.34 ± 0.89 
HDL cholesterol (mmol/L) 1.52 ± 0.40  1.43 ± 0.39  1.67 ± 0.38 
Triglycerides (mmol/L)* 1.01 (0.69-1.42)  1.19 (0.80-1.67)  0.77 (0.56-0.99)
Family history of diabetes (%) 11.9   12.8   10.5  
Smoking (%)           
     Never 53.7   28.7   96.9  
     Ex-smoker 7.4   11.5   0.5  
     Current smoker 38.9   59.8   2.6  
Alcohol drinking (%)            
     Nondrinker 43.8   21.5   82.6  
     Occasional drinker 2.5   2.2   3.0  
     Light drinker 41.0   56.9   13.2  
     Moderate/heavy drinker 12.7   19.3   1.2  
Habitual exercise (%)            
     No 70.9   66.5   78.3  
     Weak 17.1   19.5   13.2  
     Moderate 8.8   9.9   6.9  
     Strong 3.2   4.1   1.6  
Prevalence of high blood pressure† (%) 29.5   36.0   18.2  
Prevalence of dyslipidemia† (%) 21.3   29.7    6.8  
Values are means ± standard deviation or %. 
*Values are geometric means (interquartile range). 
†High blood pressure and dyslipidemia were defined by Japanese criteria of metabolic syndrome.  
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Table 2. Age- and sex-adjusted and multivariate-adjusted hazard ratios for the incidence of type 2 diabetes according to sex-specific quintile of waist circumference 
  Waist circumference quintile 
Parameter Q1  Q2  Q3 Q4 Q5 
Range of waist circumference, men (cm) 51.0-73.0 73.5-78.0  78.5-82.0 82.5-86.0 86.5-110.0 
Range of waist circumference, women (cm) 54.0-65.0  65.5-69.0  69.5-73.5 74.0-80.0 80.5-120.0 
Participants (n) 852 803  820 765 752 
Age (y) 43.7 ± 5.7 44.3 ± 5.7  44.4 ± 5.9 44.7 ± 5.8 45.0 ± 5.9 
Fasting plasma glucose (mmol/L) 4.90 ± 0.49 4.93 ± 0.46  4.99 ± 0.46 5.05 ± 0.52 5.09 ± 0.49 
HbA1c (%) 5.0 ± 0.4 5.0 ± 0.4  5.0 ± 0.4 5.0 ± 0.4 5.1 ± 0.4 
Fasting insulin (μU/mL) 4.1 ± 3.9 4.7 ± 3.4  5.3 ± 3.3 6.3 ± 4.0 7.7 ± 5.7 
HOMA-IR* 0.75 (0.54-1.05) 0.88 (0.61-1.24)  1.04 (0.72-1.46) 1.22 (0.86-1.67) 1.48 (1.07-2.06) 
HOMA-B* 53.4 (37.9-75.0) 60.2 (41.5-83.5)  66.8 (48.0-90.0) 75.0 (53.3-106.7) 87.9 (63.5-120.0) 
Family history of diabetes (%) 10.7  11.7   13.3  10.2  13.8  
Prevalence of high blood pressure† (%) 21.5  24.8   28.4  35.6  38.7  
Prevalence of dyslipidemia† (%) 7.9  14.8   21.5  26.0  38.7  
 
Total person-years 6,143 5,787  5,689  5,242 5,000 
Incident cases (n) 39 23  34  58 64 
Rate per 1,000 person-years 6.3  4.0   6.0   11.1  12.8  
Adjusted hazard ratio (95%CI) (Model 1) 1.78 (1.06-2.98) 1.00 (reference)  1.59 (0.94-2.71)  3.11 (1.92-5.04) 3.30 (2.05-5.31) 
Adjusted hazard ratio (95%CI) (Model 2) 1.81 (1.08-3.04) 1.00 (reference)  1.62 (0.95-2.76)  3.27 (2.01-5.31) 3.37 (2.09-5.43) 
Adjusted hazard ratio (95%CI) (Model 3) 1.90 (1.13-3.19) 1.00 (reference)  1.50 (0.88-2.56)  2.82 (1.73-4.61) 2.72 (1.67-4.42) 
Adjusted hazard ratio (95%CI) (Model 4) 1.62 (0.96-2.72)  1.00 (reference)  1.18 (0.69-2.01)   2.10 (1.28-3.46) 2.03 (1.24-3.33) 
Model 1, adjusted for age and sex; Model 2, adjusted for age, sex, family history of diabetes, smoking, alcohol drinking, and habitual exercise; Model 3, adjusted for variables used 
in Model 2 and presence of hypertension and hyperlipidemia at baseline; Model 4, adjusted for variables used in Model 3 and fasting plasma glucose level. 
*Values are geometric means (interquartile range). 





Table 3. Age- and sex-adjusted and multivariate-adjusted hazard ratios for incidence of type 2 diabetes according to sex-specific quintile of body mass index 
  Body mass index quintile 
Parameter Q1  Q2  Q3 Q4  Q5 
Range of body mass index, men (kg/m2) 15.8-20.9  21.0-22.4  22.5-23.8 23.9-25.4  25.5-33.9 
Range of body mass index, women (kg/m2) 15.2-19.9  20.0-21.4  21.5-22.8 22.9-24.9  25.0-41.3 
Participants (n) 807  813  790 799  783 
Age (y) 43.5 ± 5.6  44.1 ± 5.9  44.7 ± 5.8 44.8 ± 5.8  44.9 ± 5.9 
Fasting plasma glucose (mmol/L) 4.91 ± 0.50  4.94 ± 0.47  4.98 ± 0.49 5.03 ± 0.48  5.09 ± 0.49 
HbA1c (%) 5.0 ± 0.4  5.0 ± 0.4  5.0 ± 0.4 5.0 ± 0.4  5.1 ± 0.4 
Fasting insulin (μU/mL) 4.0 ± 3.0  4.7 ± 3.7  5.5 ± 4.0 6.1 ± 4.9  7.7 ± 4.7 
HOMA-IR* 0.75 (0.54-1.06)  0.88 (0.63-1.20)  1.04 (0.74-1.48) 1.16 (0.82-1.61)  1.51 (1.08-2.11) 
HOMA-B* 53.1 (37.2-72.0)  59.3 (41.5-83.1)  68.1 (49.1-94.7) 72.2 (51.4-98.5)  89.2 (65.5-120.0) 
Family history of diabetes (%) 11.6   12.1   10.6  10.5   14.8  
Prevalence of high blood pressure† (%) 22.4   23.5   28.4  32.7   41.0  
Prevalence of dyslipidemia† (%) 9.4   15.1   19.0  26.3   37.4  
                   
Total person-years 5,781  5,836  5,492 5,518 5,234 
Incident cases (n) 36  27  31 50 74 
Rate per 1,000 person-years 6.2  4.6   5.6  9.1  14.1  
Adjusted hazard ratio (95%CI) (Model 1) 1.40 (0.85-2.30)  1.00 (reference)  1.21 (0.72-2.03) 1.97 (1.23-3.14)  3.06 (1.97-4.75) 
Adjusted hazard ratio (95%CI) (Model 2) 1.36 (0.82-2.24)  1.00 (reference)  1.23 (0.74-2.07) 2.02 (1.26-3.23)  3.00 (1.93-4.67) 
Adjusted hazard ratio (95%CI) (Model 3) 1.42 (0.86-2.35)  1.00 (reference)  1.18 (0.70-1.98) 1.78 (1.11-2.85)  2.46 (1.57-3.86) 
Adjusted hazard ratio (95%CI) (Model 4) 1.27 (0.77-2.10)  1.00 (reference)  1.03 (0.61-1.73) 1.59 (0.99-2.56)  2.06 (1.31-3.24) 
Model 1, adjusted for age and sex; Model 2, adjusted for age, sex, family history of diabetes, smoking, alcohol drinking, and habitual exercise; Model 3, adjusted for variables used 
in Model 2 and presence of hypertension and hyperlipidemia at baseline; Model 4, adjusted for variables used in Model 3 and fasting plasma glucose level. 
*Values are geometric means (interquartile range). 






Table 4. Difference in baseline insulin sensitivity (HOMA-R) and beta-cell function (HOMA-B) between subjects who developed type 2 diabetes and those who did 
not, across the sex-specific quintile of baseline waist circumference or body mass index 
  HOMA-IR HOMA-B 
   No diabetes Incident diabetes p* No diabetes Incident diabetes p* 
Waist circumference 
quintile           
 Q1 (lowest) 0.75  (0.54-1.05) 0.79 (0.48-1.08) 0.561 54.8  (38.6-75.8) 31.7 (23.2-40.0) <0.001
 Q2 0.88  (0.62-1.24) 1.03 (0.76-1.35) 0.158 61.1  (42.4-85.0) 36.2 (25.7-51.4) <0.001
 Q3 1.03  (0.71-1.45) 1.23 (0.82-1.78) 0.041 67.4  (48.2-90.0) 54.0 (34.1-84.0) 0.053 
 Q4 1.20  (0.86-1.64) 1.59 (1.01-2.28) 0.003 76.4  (55.4-108.0) 60.1 (32.7-99.4) 0.025 
 Q5 (highest) 1.45  (1.30-2.02) 1.89 (1.34-2.57) <0.001 88.9  (65.5-120.0) 78.1 (50.1-106.5) 0.070 
Body mass index quintile         
 Q1 (lowest) 0.75  (0.54-1.04) 0.83 (0.50-1.15) 0.268 54.3  (37.9-74.6) 33.1 (24.1-45.0) <0.001
 Q2 0.88  (0.63-1.20) 0.99 (0.71-1.33) 0.226 60.4  (42.4-83.1) 34.8 (23.2-51.4) <0.001
 Q3 1.04  (0.73-1.48) 1.15 (0.78-1.54) 0.322 68.9  (49.7-94.7) 50.0 (30.0-74.5) 0.001 
 Q4 1.15  (0.81-1.61) 1.31 (0.85-1.80) 0.111 73.3  (53.3-99.8) 56.9 (35.0-85.5) 0.038 
 Q5 (highest) 1.46  (1.04-2.04) 2.12 (1.54-2.95) <0.001 90.2  (65.7-120.0) 80.0 (53.7-111.7) 0.087 
Values are geometric means (interquartile range). 






The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, see:  
 
http://www.textcheck.com/cgi-bin/certificate.cgi?id=i3hS7W  
 
